Howard W Robin insider trades
Open-market stock purchases and sales by Howard W Robin, President & CEO at Nektar Therapeutics, from SEC Form 4 filings since Feb 1, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | NKTR Nektar Therapeutics | Sold | $334K |
| Jun 17, 2026 | NKTR Nektar Therapeutics | Sold | $277K |
| Jun 16, 2026 | NKTR Nektar Therapeutics | Sold | $318K |
| Jun 16, 2026 | NKTR Nektar Therapeutics | Sold | $285K |
| May 19, 2026 | NKTR Nektar Therapeutics | Sold | $29.1K |
| Feb 18, 2026 | NKTR Nektar Therapeutics | Sold | $30.9K |
| Dec 22, 2025 | NKTR Nektar Therapeutics | Bought (not open market) | — |
| Dec 22, 2025 | NKTR Nektar Therapeutics | Bought (not open market) | — |
| Nov 25, 2025 | NKTR Nektar Therapeutics | Sold | $120K |
| Nov 21, 2025 | NKTR Nektar Therapeutics | Bought (not open market) | — |
| Nov 21, 2025 | NKTR Nektar Therapeutics | Bought (not open market) | — |
Companies traded
- NKTR Nektar Therapeutics: 103 sales, last Jun 17, 2026